Suncoast Equity Management Eli Lilly & CO Transaction History

Suncoast Equity Management

$896 Million
Q2 2024

A detailed history of Suncoast Equity Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Suncoast Equity Management holds 5,737 shares of LLY stock, worth $5.11 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

5,737

Previous 5,331 7.62%

Holding current value

$5.11 Million

Previous $4.15 Million 25.25%

% of portfolio

0.58%

Previous 0.49%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$724.87 - $909.04 $294,297 - $369,070	406 Added 7.62%	5,737 $5.19 Million
Q1 2024 May 02, 2024	BUY	$592.2 - $792.28 $163,447 - $218,669	276 Added 5.46%	5,331 $4.15 Million
Q4 2023 Jan 30, 2024	BUY	$525.19 - $619.13 $75,102 - $88,535	143 Added 2.91%	5,055 $2.95 Million
Q3 2023 Oct 23, 2023	SELL	$434.7 - $599.3 $214,741 - $296,054	-494 Reduced 9.14%	4,912 $2.64 Million
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $235,346 - $314,685	671 Added 14.17%	5,406 $2.54 Million
Q1 2023 May 08, 2023	BUY	$310.63 - $364.82 $54,360 - $63,843	175 Added 3.84%	4,735 $1.63 Million
Q4 2022 Jan 27, 2023	BUY	$321.55 - $374.67 $110,934 - $129,261	345 Added 8.19%	4,560 $0
Q3 2022 Oct 14, 2022	SELL	$296.48 - $337.87 $512,910 - $584,515	-1,730 Reduced 29.1%	4,215 $1.36 Million
Q2 2022 Jul 18, 2022	BUY	$278.73 - $327.27 $206,260 - $242,179	740 Added 14.22%	5,945 $1.93 Million
Q1 2022 Apr 26, 2022	BUY	$234.69 - $291.66 $68,060 - $84,581	290 Added 5.9%	5,205 $1.49 Million
Q4 2021 Jan 28, 2022	BUY	$224.85 - $279.04 $5,621 - $6,976	25 Added 0.51%	4,915 $1.36 Million
Q3 2021 Oct 29, 2021	SELL	$221.6 - $272.71 $316,888 - $389,975	-1,430 Reduced 22.63%	4,890 $1.13 Million
Q2 2021 Jul 29, 2021	BUY	$180.55 - $233.54 $41,526 - $53,714	230 Added 3.78%	6,320 $1.45 Million
Q1 2021 May 06, 2021	BUY	$164.32 - $212.72 $28,756 - $37,226	175 Added 2.96%	6,090 $1.14 Million
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $156,552 - $207,156	1,200 Added 25.45%	5,915 $999,000
Q3 2020 Oct 22, 2020	BUY	$146.22 - $169.13 $110,396 - $127,693	755 Added 19.07%	4,715 $698,000
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $540,223 - $650,152	3,960 New	3,960 $650,000

Others Institutions Holding LLY

# of Institutions

3,869

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $847B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Suncoast Equity Management, based on Form 13F filings with the SEC.

News

Stay updated on Suncoast Equity Management with notifications on news.

Account

Suncoast Equity Management Eli Lilly & CO Transaction History